Global Wealth Strategies & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Global Wealth Strategies & Associates's GILD Position: Q2 2026 in Review
Global Wealth Strategies & Associates sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 29 shares — an estimated $4.07K sold.
Global Wealth Strategies & Associates first reported a position in GILD in Q4 2022 and held it in 14 quarters. The position peaked at $10.2K in Q4 2022. 1,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Global Wealth Strategies & Associates reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Global Wealth Strategies & Associates sold 29 Gilead Sciences shares in Q2 2026, an estimated $4.07K.
- Global Wealth Strategies & Associates first reported a position in Gilead Sciences in Q4 2022 and held it in 14 quarters.
- Global Wealth Strategies & Associates's Gilead Sciences position peaked at $10.2K in Q4 2022.
- 1,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.